-
1
-
-
85120195558
-
-
Fishman NO, Suh B, Weigel LM, et al. Three levofloxacin treatment failures of pneumococcal respiratory tract infections. 39th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 1999; San Francisco. Abstract 825.
-
-
-
-
2
-
-
85120219889
-
-
Davidson RJ, DeAzavedo J, Bast D, et al. Levofloxacin treatment failure of pneumococcal pneumonia and development of resistance during therapy. 40th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 2000; Toronto. Abstract 2103.
-
-
-
-
3
-
-
85120200803
-
-
Urban C, Rahman N, Zhao X, et al. Fluoroquinolone-resistant Streptococcus pneumoniae associated with levofloxacin therapy. J Inf Dis (in press).
-
-
-
-
4
-
-
0024996317
-
Superinfection with Streptococcus penumoniae during therapy with ciprofloxacin
-
JJ Gordon CA Kaufmann Superinfection with Streptococcus penumoniae during therapy with ciprofloxacin Am J Med 89 1990 383 384
-
(1990)
Am J Med
, vol.89
, pp. 383-384
-
-
Gordon, JJ1
Kaufmann, CA2
-
5
-
-
85120188064
-
Reflection & Reaction Infectious complications with respiratory pathogens despite ciprofloxacin therapy
-
BL Lee RC Kimbrough SR Jones Reflection & Reaction Infectious complications with respiratory pathogens despite ciprofloxacin therapy N Eng J Med 25 1991 520 521
-
(1991)
N Eng J Med
, vol.25
, pp. 520-521
-
-
Lee, BL1
Kimbrough, RC2
Jones, SR3
-
6
-
-
0028206249
-
Fluoroquinolones in chronic obstructive pulmonary disease
-
A Colville M Knowles D Large Fluoroquinolones in chronic obstructive pulmonary disease BMJ 308 1994 1437
-
(1994)
BMJ
, vol.308
, pp. 1437
-
-
Colville, A1
Knowles, M2
Large, D3
-
7
-
-
0029125511
-
Lower respiratory tract infection therapy–the role of ciprofloxacin
-
AP Ball GS Tillotson Lower respiratory tract infection therapy–the role of ciprofloxacin Int J Med Res 23 1995 315 327
-
(1995)
Int J Med Res
, vol.23
, pp. 315-327
-
-
Ball, AP1
Tillotson, GS2
-
8
-
-
0031031527
-
Trends in bacterial resistance to fluoroquinolones
-
J Acar F Goldstein Trends in bacterial resistance to fluoroquinolones Clin Infect Dis 24 1997 S67 S73
-
(1997)
Clin Infect Dis
, vol.24
, pp. S67-S73
-
-
Acar, J1
Goldstein, F2
-
9
-
-
0029794181
-
Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae
-
X-S Pan J Ambler S Mehtar LM Fisher Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae Antimicrob Agents Chemother 40 1996 2321 2326
-
(1996)
Antimicrob Agents Chemother
, vol.40
, pp. 2321-2326
-
-
Pan, X-S1
Ambler, J2
Mehtar, S3
Fisher, LM4
-
10
-
-
0035882293
-
A nosocomial outbreak of fluoroquinolone-resistant Streptococcus pneumoniae
-
K Weiss C Restieri R Gauthier A nosocomial outbreak of fluoroquinolone-resistant Streptococcus pneumoniae Clin Infect Dis 33 2001 517 522
-
(2001)
Clin Infect Dis
, vol.33
, pp. 517-522
-
-
Weiss, K1
Restieri, C2
Gauthier, R3
-
11
-
-
0032803964
-
Effect of fluoroquinolone concentration on selection of resistant mutants of Mycobacterium bovis BCG and Staphylococcus aureus
-
Y Dong X Zhao J Domagala K Drlica Effect of fluoroquinolone concentration on selection of resistant mutants of Mycobacterium bovis BCG and Staphylococcus aureus Antimicrob Agents Chemother 43 1999 1756 1758
-
(1999)
Antimicrob Agents Chemother
, vol.43
, pp. 1756-1758
-
-
Dong, Y1
Zhao, X2
Domagala, J3
Drlica, K4
-
12
-
-
0028227016
-
Comparative pharmacokinetics and safety of ciprofloxacin 400 mg iv thrice daily versus 750 mg PO twice daily
-
A Shah J Lettieri L Kaiser R Echols A Heller Comparative pharmacokinetics and safety of ciprofloxacin 400 mg iv thrice daily versus 750 mg PO twice daily J Antimicrob Chemother 33 1994 795 801
-
(1994)
J Antimicrob Chemother
, vol.33
, pp. 795-801
-
-
Shah, A1
Lettieri, J2
Kaiser, L3
Echols, R4
Heller, A5
-
13
-
-
0030864108
-
Pharmacokinetic profile of levofloxacin following once-daily 500 mg oral or intravenous doses
-
S-H Chien McRogge L Gisclon Pharmacokinetic profile of levofloxacin following once-daily 500 mg oral or intravenous doses Antimicrob Agents Chemother 41 1997 2256 2260
-
(1997)
Antimicrob Agents Chemother
, vol.41
, pp. 2256-2260
-
-
Chien, S-H1
McRogge2
Gisclon, L3
-
14
-
-
0032929072
-
In vitro activity of quinolones
-
A Dalhoff In vitro activity of quinolones Exp Opin Invest Drugs 8 1999 123 137
-
(1999)
Exp Opin Invest Drugs
, vol.8
, pp. 123-137
-
-
Dalhoff, A1
-
15
-
-
0035139520
-
Mutant prevention concentrations (MPC) for fluoroquinolones with clinical isolates of Streptococcus pneumoniae
-
J Blondeau X Zhao G Hansen K Drlica Mutant prevention concentrations (MPC) for fluoroquinolones with clinical isolates of Streptococcus pneumoniae Antimicrob Agents Chemother 45 2001 433 438
-
(2001)
Antimicrob Agents Chemother
, vol.45
, pp. 433-438
-
-
Blondeau, J1
Zhao, X2
Hansen, G3
Drlica, K4
-
16
-
-
0025874801
-
Antistaphylococcal activity of the fluoroquinolones CI-960, PD131628, sparfloxacin, ofloxacin, and ciprofloxacin
-
AL Barry PC Fuchs Antistaphylococcal activity of the fluoroquinolones CI-960, PD131628, sparfloxacin, ofloxacin, and ciprofloxacin Eur J Clin Microbiol Infect Dis 10 1991 168 171
-
(1991)
Eur J Clin Microbiol Infect Dis
, vol.10
, pp. 168-171
-
-
Barry, AL1
Fuchs, PC2
-
17
-
-
0025142610
-
Antistaphylococcal activities of sparfloxacin (CI-978; AT-4140), ofloxacin, and ciprofloxacin
-
A Chaudhry C Knapp J Sierra-Madero J Washington Antistaphylococcal activities of sparfloxacin (CI-978; AT-4140), ofloxacin, and ciprofloxacin Antimicrob Agents Chemother 34 1990 1843 1845
-
(1990)
Antimicrob Agents Chemother
, vol.34
, pp. 1843-1845
-
-
Chaudhry, A1
Knapp, C2
Sierra-Madero, J3
Washington, J4
-
18
-
-
0033485614
-
Molecular epidemiology of quinolone resistance and comparative in vitro activities of new quinolones against European Staphylococcus aureus isolates. FEMS
-
F-J Schmitz A Fluit S Brisse J Verhoef K Koher D Milatovic Molecular epidemiology of quinolone resistance and comparative in vitro activities of new quinolones against European Staphylococcus aureus isolates. FEMS Immunol Med Microbiol 26 1999 281 287
-
(1999)
Immunol Med Microbiol
, vol.26
, pp. 281-287
-
-
Schmitz, F-J1
Fluit, A2
Brisse, S3
Verhoef, J4
Koher, K5
Milatovic, D6
-
19
-
-
0035077214
-
Need for annual surveillance of antimicrobial resistance in Streptococcus pneumoniae in the United States: 2-year longitudinal analysis
-
D Sahm J Karlowsky L Kelly Need for annual surveillance of antimicrobial resistance in Streptococcus pneumoniae in the United States: 2-year longitudinal analysis Antimicrob Agents Chemother 45 2001 1037 1042
-
(2001)
Antimicrob Agents Chemother
, vol.45
, pp. 1037-1042
-
-
Sahm, D1
Karlowsky, J2
Kelly, L3
|